Aberdeen Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Aberdeen Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-438	Closed	-$255K	–	177
2024 Q1	$255K	Hold	438	–	–	0.15%	135
2023 Q4	$232K	Hold	438	–	–	0.17%	135
2023 Q3	$222K	Hold	438	–	–	0.17%	134
2023 Q2	$229K	Buy	438 +35	+9%	+$18.9K	0.17%	132
2023 Q1	$232K	Hold	403	–	–	0.17%	134
2022 Q4	$222K	Hold	403	–	–	0.17%	138
2022 Q3	$204K	Hold	403	–	–	0.18%	133
2022 Q2	$219K	Hold	403	–	–	0.17%	135
2022 Q1	$238K	Hold	403	–	–	0.16%	136
2021 Q4	$269K	Buy	403 +30	+8%	+$18.7K	0.18%	122
2021 Q3	$213K	Sell	373 -27	-7%	-$14.8K	0.21%	119
2021 Q2	$202K	Buy	+400	New	+$189K	0.19%	126
2021 Q1	–	Sell	-528	Closed	-$246K	–	154
2020 Q4	$246K	Buy	+528	New	+$248K	0.19%	122
2020 Q3	–	Sell	-578	Closed	-$209K	–	147
2020 Q2	$209K	Buy	+578	New	+$194K	0.22%	119

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Aberdeen Wealth Management's TMO Position: Q2 2024 in Review

Aberdeen Wealth Management sold out of Thermo Fisher Scientific (TMO) in Q2 2024, closing a stake of 438 shares — an estimated $255K sold.

Aberdeen Wealth Management first reported a position in TMO in Q2 2020 and held it in 14 quarters. The position peaked at $269K in Q4 2021. 2,542 funds tracked by Wall St. Rank hold TMO as of Q2 2024.

Aberdeen Wealth Management reported no remaining Thermo Fisher Scientific position as of Q2 2024 after selling out during the quarter.
Aberdeen Wealth Management sold 438 Thermo Fisher Scientific shares in Q2 2024, an estimated $255K.
Aberdeen Wealth Management first reported a position in Thermo Fisher Scientific in Q2 2020 and held it in 14 quarters.
Aberdeen Wealth Management's Thermo Fisher Scientific position peaked at $269K in Q4 2021.
2,542 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.

Based on Aberdeen Wealth Management's 13F filing for Q2 2024, filed 2 Aug 2024.